buying oppurtunity

I've been following this stock for about a year now and given the current circumstances the present price is cheap. When ATC hits the market, not if but WHEN, this company is going to make serious $. In the same vein as PXS it will go from being a biotec to a fully pledged pharmaceutical co. All broker reports I've read CONSERVATIVELY give this company a present value in excess of a $1. Current weakness in price is a buying op.

I'm on board for more.

DYOR.